Is routine skin examination in metastatic melanoma patients treated with immuno- or targeted therapy necessary?

J Eur Acad Dermatol Venereol. 2020 Apr;34(4):e175-e176. doi: 10.1111/jdv.16128. Epub 2019 Dec 20.

Authors

E A Huis In't Veld¹, I C van Seventer¹, L van Teeseling¹, J V van Thienen², M B Crijns¹

Affiliations

¹ Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
² Department of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.

PMID: 31793062
DOI: 10.1111/jdv.16128

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Disease Progression
Female
Humans
Immunotherapy
Male
Melanoma / drug therapy*
Melanoma / mortality
Middle Aged
Molecular Targeted Therapy
Physical Examination*
Skin Neoplasms / drug therapy*
Skin Neoplasms / mortality
Survival Analysis